Analysts Offer Insights on Healthcare Companies: ProSomnus (OSA), Merck & Company (MRK) and Phreesia (PHR)
Craig-Hallum Reaffirms Their Hold Rating on ProSomnus (OSA)
Alliance Global Partners Initiates Coverage On ProSomnus With Buy Rating, Announces Price Target of $2
ProSomnus Analyst Ratings
Craig-Hallum Downgrades ProSomnus to Hold, Announces $1 Price Target
ProSomnus Analyst Ratings
ResMed Upgraded at JPMorgan; Says GLP-1 Threat Overdone
Roth MKM Maintains Buy on ProSomnus, Lowers Price Target to $4
ProSomnus Analyst Ratings
Craig-Hallum Sticks to Their Buy Rating for ProSomnus (OSA)
Roth MKM Initiates Coverage On ProSomnus With Buy Rating, Announces Price Target of $9
Analysts Offer Insights on Healthcare Companies: Danaher (DHR) and ProSomnus (OSA)
Craig-Hallum Initiates Coverage On ProSomnus With Buy Rating, Announces Price Target of $10
ProSomnus (OSA) Receives a New Rating From Craig-Hallum
No Data